We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Temuchin, they couldn't afford it! They haven't got hundreds of millions spare just yet, lol. Let's just see what net profits they make out of all this as they outsource one hell of a lot.
Sorcerer, it seems they think it may be difficult to get accuracy with the rapid saliva test (over 90%).It hasn't stopped everyone else bull****ting about their accuracy claims.
I was going to say only 1 MM left on the ask but quicker than I could type, they moved to 20p .. We now have 3MM's on the bid at 19p (90k) and two on the ask at 20p (60k) .. latest live trade, a buy of 79694 buy at 19.98p
Dan of course not, but you realise what everyone is waiting for, including brokers/analysts etc. Show us yer figures.
Natdan - is it in anyone’s interest to keep damning progress?
JAdam, perhaps an element of ambiguity with the announcement- I am sure the webinar made reference to CQC already granted but this RNS seems to refer to YGEN’s second premises being afforded that permission.
Is the second premises the original NIPT HQ?
If so, this is an aged, unassuming premises which I have previously visited, and I expect is not one would now like to associate with a Co. in expansionist/ world domination mode.
May have misread the RNS, and stand to be corrected if anyone is able to clarify.
I took it as a passing reference that it had been looked at ... certainly not a commitment as such ... I may be wrong as I often am , LOL
I was not aware we were moving beyond our core PCR and NGS technologies.
Good news, so should mean an increased testing capacity and more work.
None of it is bad.
"Only wishing to focus on PCR tests etc." ????
I am confused ... Clarigene IS a PCR test ???
No comment.
A damp squib of an announcement really, seems Ygen has swung the other way now by providing an RNS for each and every occasion.
All eyes are firmly fixed eagerly upon the quarterly re COVID testing, so why not just bring it on? Expectations need to be managed with some long overdue numbers.
Manchester, UK - 23 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received notification from the Care Quality Commission ("CQC") that the Company's facilities at Citylabs 1.0 in Manchester are now a second accredited location from which to perform diagnostics and screening procedures.
The extension of the Company's current CQC registration allows NIPT testing greater flexibility to operate from both Yourgene Health locations in Manchester, and confirms that the Company's COVID-19 testing services meet the demanding standards of the CQC. As announced on 28 September 2020, the launch of Yourgene Genomic Services consolidates the Company's established NIPT and rapidly growing COVID-19 testing services in Manchester and this accreditation supports this strategy. The CQC registration supports the Company's continued scale up in capacity for COVID-19 testing for both private and public market segments.
The CQC is an independent regulator of health and social care in England and ensures, amongst other things, that services are safe, high-quality, effective and meet legal standards.
The extension of the Company's current CQC registration allows NIPT testing greater flexibility to operate from both Yourgene Health locations in Manchester, and confirms that the Company's COVID-19 testing services meet the demanding standards of the CQC. As announced on 28 September 2020, the launch of Yourgene Genomic Services consolidates the Company's established NIPT and rapidly growing COVID-19 testing services in Manchester and this accreditation supports this strategy. The CQC registration supports the Company's continued scale up in capacity for COVID-19 testing for both private and public market segments.
The CQC is an independent regulator of health and social care in England and ensures, amongst other things, that services are safe, high-quality, effective and meet legal standards.